Publication | Closed Access

Survival and Response After Peptide Receptor Radionuclide Therapy With [90Y-DOTA0,Tyr3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

MedicineRadionuclide TherapyPathologyRadiopharmaceutical TherapyCancer TreatmentRadiation OncologyOncologyGliomaNuclear MedicineCancer ResearchRadiologyHealth Sciences